For the seventh time in a row, NYU Langone Health has earned top safety ratings for its inpatient locations across the system, with each receiving “A” ratings in the fall 2023 Leapfrog Hospital Safety Grade release, a level of patient safety achieved by only 30 percent of hospitals nationwide.
FDA rejects Alvotech’s Humira biosimilar for the third time
The FDA has rejected Alvotech’s Humira biosimilar for the third time. Credit: Shutterstock / Jennie Book. The US Food and Drug Administration (FDA) has issued
June 29, 2023